3 million, according to FactSet.at some stage in the quarter GenMark took an range charge of $421,000, or else 2 cents apiece share, to contact inedible the cost of assay production lots with the aim of didnt pick up its values. The charge as well covered inefficiencies to were linked to the relocation of its manufacturing operations to Carlsbad from Pasadena, Calif.GenMark held reagent sales rose to $1.2 million from $656,000, while instrument and other revenue rose to $110,000 from $28,000.GenMark shares fell 16 cents, before 3.